Capvizr
News · All summaries
Healthcare & Life Sciences
Delix Therapeutics
Series CUndisclosed
RoundSeries C
AmountUndisclosed
DateNovember 9, 2026
THE DEAL, AT A GLANCE

Delix Therapeutics

From the announcement
What happenedDelix Therapeutics raised Series C, announced 2026-11-09From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersDelix Therapeutics' Series C is recorded at $0M, while the company description states a $100 Million financing.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Delix Therapeutics · Financing Record

Explore source-linked visual explanations for Delix Therapeutics. Unsupported claims are withheld while source review continues.

Record 15650 · Recorded date: 2026-11-09

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime